Araris Biotech's Up to $1.14 Billion Acquisition by Taiho Pharmaceutical
March 18, 2025
March 18, 2025
PALO ALTO, California, March 18 -- Cooley, a law firm, issued the following news release:
* * *
Araris Biotech's up to $1.14 Billion Acquisition by Taiho Pharmaceutical
New York - March 17, 2025 - Cooley advised Araris Biotech, a Swiss biotechnology company developing next-generation antibody-drug conjugates, on its definitive agreement to be acquired by Japan-based Taiho Pharmaceutical for up to $1.14 billion in cash.
Under the terms of . . .
* * *
Araris Biotech's up to $1.14 Billion Acquisition by Taiho Pharmaceutical
New York - March 17, 2025 - Cooley advised Araris Biotech, a Swiss biotechnology company developing next-generation antibody-drug conjugates, on its definitive agreement to be acquired by Japan-based Taiho Pharmaceutical for up to $1.14 billion in cash.
Under the terms of . . .